Milestone Scientific’s (MLSS) “Speculative Buy” Rating Reiterated at Benchmark

Benchmark reiterated their speculative buy rating on shares of Milestone Scientific (NYSE:MLSS) in a report issued on Wednesday morning,Benzinga reports. They currently have a $1.25 price objective on the stock.

Separately, StockNews.com started coverage on Milestone Scientific in a research note on Monday, November 18th. They set a “hold” rating on the stock.

Milestone Scientific Stock Up 9.3 %

MLSS stock opened at $0.77 on Wednesday. The firm has a market capitalization of $60.29 million, a PE ratio of -11.06 and a beta of 1.08. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.10. The stock’s 50 day moving average is $0.83 and its 200-day moving average is $0.84.

Insider Buying and Selling at Milestone Scientific

In related news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the sale, the director now directly owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In the last 90 days, insiders sold 109,193 shares of company stock worth $101,634. Insiders own 24.75% of the company’s stock.

Institutional Investors Weigh In On Milestone Scientific

An institutional investor recently bought a new position in Milestone Scientific stock. Y Intercept Hong Kong Ltd purchased a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 52,368 shares of the company’s stock, valued at approximately $48,000. Y Intercept Hong Kong Ltd owned 0.07% of Milestone Scientific as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.